ChoA Pharmaceutical Co., LTD.

Informe acción KOSDAQ:A034940

Capitalización de mercado: ₩29.7b

ChoA Pharmaceutical Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Sung-Hwan Cho

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO6.1%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Nov 12
ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt

Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

Aug 12
Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?

ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet

Jan 31
ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet

Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?

Dec 09
Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?

CEO

Sung-Hwan Cho (54 yo)

no data

Permanencia

Mr. Cho Sung-Hwan serves as Managing Director of Kwang Myung Electric Engineering Co. Ltd. Mr. Sung-Hwan serves as the Chief Executive Officer of ChoA Pharmaceutical Co. Ltd. and Medipharm Co., Ltd.Mr. Su...